Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin co-administration to reduce doxorubicin cardiotoxicity in breast cancer patients
IRCT20190303042892N1Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of quercetin in breast cancer, sponsored by Guilan University of Medical Sciences. Started May 2018; status: completed.
02
Drugs
quercetin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20190303042892N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190303042892N1.